Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stoke Therapeutics Inc (NQ: STOK )

3.870 -0.310 (-7.42%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 163,256
Open 4.160
Bid (Size) 3.790 (1)
Ask (Size) 4.190 (1)
Prev. Close 4.180
Today's Range 3.860 - 3.965
52wk Range 3.860 - 16.48
Shares Outstanding 44,188,534
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stocks That Hit 52-Week Lows On Thursday
  During the session on Thursday, 461 stocks hit new 52-week lows. 
Via Benzinga
The Latest Analyst Ratings for Stoke Therapeutics
Via Benzinga

Performance

YTD
-57.43%
-57.43%
1 Month
-33.73%
-33.73%
3 Month
-62.91%
-62.91%
6 Month
-51.50%
-51.50%
1 Year
-69.19%
-69.19%

More News

Read More
What 8 Analyst Ratings Have To Say About Stoke Therapeutics
Via Benzinga
Stoke Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference
From Stoke Therapeutics, Inc.
Via Business Wire
Stoke Therapeutics Appoints Ian Smith to its Board of Directors
From Stoke Therapeutics, Inc.
Via Business Wire
Stoke Therapeutics Presents Data Related to the Ongoing Clinical Development of STK-001 for the Treatment of Dravet Syndrome at the 35th International Epilepsy Congress
From Stoke Therapeutics, Inc.
Via Business Wire
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street
Via The Motley Fool
Stoke Therapeutics Reports Second Quarter Financial Results and Provides Business Updates
From Stoke Therapeutics, Inc.
Via Business Wire
Stoke Therapeutics to Present at the Canaccord Genuity 43rd Annual Growth Conference
From Stoke Therapeutics, Inc.
Via Business Wire
Stocks That Hit 52-Week Lows On Thursday
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Why Shares of Stoke Therapeutics Plummeted Tuesday
Via The Motley Fool
Crude Oil Up 1%; Verizon Earnings Beat Views
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Why Stoke Therapeutics Is Trading Lower Today?
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Stoke Therapeutics Announces Positive New Safety & Efficacy Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome
From Stoke Therapeutics, Inc.
Via Business Wire
Scholastic, Matson, Digital World Acquisition And Other Big Stocks Moving Higher On Friday
Via Benzinga
Stoke Therapeutics to Host Webinar to Present New Data from Patients Treated with STK-001 in the Phase 1/2a Studies (MONARCH & ADMIRAL) and the SWALLOWTAIL Open-Label Extension (OLE) Study in Children and Adolescents with Dravet Syndrome
From Stoke Therapeutics, Inc.
Via Business Wire
Why Ryanair Holdings Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
From Stoke Therapeutics, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.